Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157: The peptide with big claims and scant evidence STAT The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA mulls compounding for peptides previously flagged over safety risks BioSpace Is BPC 157 Banned? Oral vs. Injectable Forms Explained